AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Endo-ePIcardial Versus Endocardial Only Catheter Ablation for ISchemic Driven Ventricular Tachycardia (EPISODE VT)

RecruitingNAAges 18 Years - 85 YearsAllMEDICOVER SP Z O.O.
💬

In plain words

What the trial is, and whether it could suit you

The EPISODE VT trial is designed to compare efficacy and safety of two modalities for interventional treatment - endocardial ablation and endo-epicardial ablation in a population of patients with post myocardial infarction (ICD 10 - I25.2) ventricular tachycardias (ICD 10 - I47.2), who are protected by an implantable cardioverter-defibrilator (ICD) and meet study inclusion criteria.

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Status after myocardial infarction (minimum 3 months before inclusion in the study). * Documented post-infarction VT or VF. * Implantable ICD (at least 2 weeks before ablation) or CRT-D (at least 2 months before ablation). * A history of at least one from below: 1. One or more high energy interventions. 2. Three or more adequate antitachycardia pacing therapies, including one symptomatic. 3. Three or more episodes of VT in 24 hours (interrupted by ATP or shock) - electrical storm. 4. Sustained VT recorded on ECG with a cycle length longer than the ICD detection threshold. * Age between 18 and 85 years. * Signed informed consent to participate in the study. Exclusion Criteria: * Obesity with BMI \> 40 kg/m2. * Left ventricle ejection fraction \< 20%. * Pregnancy or breastfeeding. * Renal failure (eGFR \< 20 mL/min/1.73m2). * Fresh ballot thrombus in the left ventricle. * Suspicion of massive adhesions in the pericardium that may impede pericardial puncture. * Ablation of the post-infarction VT in the left ventricle in medical history. * Previous heart surgery. * Acute conditions that prevent ablation (including active infection, overt hyperthyroidism and others listed below). * Active neoplastic disease. * Heart failure with NYHA IV. * Life expectancy less than 12 months.
💊

What it tests

  • Endocardial VT ablation
  • Endo-epicardial VT ablation
📍

Where

9 sites
Medicover Hospital
Warsaw, Poland
Medical University of Warsaw
Warsaw, Poland
National Institute of Cardiology
Warsaw, Poland
University Hospital No. 1 in Bydgoszcz
Bydgoszcz, Poland
University Clinical Center based in Gdańsk
Gdansk, Poland
Independent Public Health Care Facility University Hospital in Krakow
Krakow, Poland
University Clinical Hospital in Poznań
Poznan, Poland
University Clinical Hospital No. 2 PUM in Szczecin
Szczecin, Poland

…and 1 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy